Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.80)
# 3,343
Out of 5,090 analysts
340
Total ratings
29.67%
Success rate
-9.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $2.44 | +680.29% | 13 | Nov 25, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $52 → $51 | $43.05 | +18.47% | 13 | Nov 24, 2025 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $56 → $48 | $27.43 | +74.99% | 3 | Nov 20, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $28 → $36 | $27.46 | +31.10% | 22 | Nov 18, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $12 → $15 | $3.68 | +307.61% | 2 | Nov 12, 2025 | |
| SANA Sana Biotechnology | Maintains: Buy | $11 → $9 | $5.17 | +74.08% | 12 | Nov 7, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $5 | $1.03 | +387.80% | 13 | Nov 6, 2025 | |
| VTYX Ventyx Biosciences | Upgrades: Buy | $18 | $7.99 | +125.28% | 16 | Nov 5, 2025 | |
| NVCR NovoCure | Maintains: Buy | $38 → $42 | $11.75 | +257.60% | 19 | Oct 30, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $24 → $28 | $25.26 | +10.85% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $72 | $34.40 | +109.30% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.22 | +440.54% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $31.46 | +90.72% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.68 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.08 | +463.73% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $12.33 | +224.54% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $12.20 | +186.81% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $27.18 | +32.45% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.91 | +775.75% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.80 | +136.84% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.87 | +972.39% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $12.93 | +178.42% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $68.14 | +68.78% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $8.59 | +3,159.60% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.55 | +213.73% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.72 | +535.59% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.85 | +872.97% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $4.04 | +4,419.94% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.76 | +822.88% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.26 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.41 | +1,176.60% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.85 | +3,794.26% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.71 | - | 1 | Apr 25, 2024 |
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $2.44
Upside: +680.29%
AnaptysBio
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $43.05
Upside: +18.47%
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Buy
Price Target: $56 → $48
Current: $27.43
Upside: +74.99%
Olema Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $28 → $36
Current: $27.46
Upside: +31.10%
Artiva Biotherapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $3.68
Upside: +307.61%
Sana Biotechnology
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $5.17
Upside: +74.08%
Context Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $1.03
Upside: +387.80%
Ventyx Biosciences
Nov 5, 2025
Upgrades: Buy
Price Target: $18
Current: $7.99
Upside: +125.28%
NovoCure
Oct 30, 2025
Maintains: Buy
Price Target: $38 → $42
Current: $11.75
Upside: +257.60%
Arcus Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $24 → $28
Current: $25.26
Upside: +10.85%
Oct 27, 2025
Maintains: Buy
Price Target: $27 → $72
Current: $34.40
Upside: +109.30%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $2.22
Upside: +440.54%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $31.46
Upside: +90.72%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.68
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $4.08
Upside: +463.73%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $12.33
Upside: +224.54%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $12.20
Upside: +186.81%
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $27.18
Upside: +32.45%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.91
Upside: +775.75%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.80
Upside: +136.84%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.87
Upside: +972.39%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $12.93
Upside: +178.42%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $68.14
Upside: +68.78%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $8.59
Upside: +3,159.60%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.55
Upside: +213.73%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $4.72
Upside: +535.59%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.85
Upside: +872.97%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $4.04
Upside: +4,419.94%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.76
Upside: +822.88%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.26
Upside: -
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.41
Upside: +1,176.60%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.85
Upside: +3,794.26%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.71
Upside: -